Wedge Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$916K Sell
764
-81
-10% -$82.8K 0.02% 418
2026
Q1
$777K Buy
845
+110
+15% +$112K 0.01% 456
2025
Q4
$790K Buy
735
+137
+23% +$131K 0.01% 454
2025
Q3
$456K Sell
598
-53
-8% -$39.4K 0.01% 487
2025
Q2
$507K Sell
651
-87
-12% -$67.6K 0.01% 473
2025
Q1
$610K Buy
738
+90
+14% +$74.9K 0.01% 468
2024
Q4
$500K Sell
648
-228
-26% -$189K 0.01% 473
2024
Q3
$776K Buy
876
+29
+3% +$26.1K 0.01% 439
2024
Q2
$767K Sell
847
-3
-0.4% -$2.4K 0.01% 425
2024
Q1
$661K Buy
850
+83
+11% +$59.1K 0.01% 445
2023
Q4
$447K Sell
767
-26
-3% -$15.2K 0.01% 450
2023
Q3
$426K Sell
793
-652
-45% -$336K 0.01% 437
2023
Q2
$678K Sell
1,445
-36
-2% -$15.1K 0.01% 467
2023
Q1
$509K Sell
1,481
-4
-0.3% -$1.35K 0.01% 313
2022
Q4
$543K Buy
1,485
+28
+2% +$9.93K 0.01% 309
2022
Q3
$471K Sell
1,457
-61
-4% -$19.3K 0.01% 315
2022
Q2
$492K Hold
1,518
0.01% 317
2022
Q1
$435K Sell
1,518
-72
-5% -$18.5K 0.01% 320
2021
Q4
$439K Hold
1,590
0.01% 332
2021
Q3
$367K Sell
1,590
-17
-1% -$4.2K ﹤0.01% 335
2021
Q2
$369K Sell
1,607
-332
-17% -$66.7K ﹤0.01% 326
2021
Q1
$362K Sell
1,939
-285
-13% -$55.7K ﹤0.01% 413
2020
Q4
$376K Buy
2,224
+92
+4% +$13.7K ﹤0.01% 440
2020
Q3
$316K Buy
2,132
+133
+7% +$20.6K ﹤0.01% 436
2020
Q2
$328K Sell
1,999
-31
-2% -$4.76K ﹤0.01% 407
2020
Q1
$282K Sell
2,030
-73
-3% -$10K ﹤0.01% 410
2019
Q4
$276K Buy
2,103
+13
+0.6% +$1.51K ﹤0.01% 486
2019
Q3
$234K Buy
2,090
+68
+3% +$7.57K ﹤0.01% 520
2019
Q2
$224K Buy
+2,022
New +$238K ﹤0.01% 578
2016
Q1
Sell
-460,590
Closed -$38.8M 591
2015
Q4
$38.8M Sell
460,590
-4,100
-0.9% -$340K 0.41% 79
2015
Q3
$38.9M Sell
464,690
-59,925
-11% -$5.06M 0.41% 61
2015
Q2
$43.8M Sell
524,615
-205,325
-28% -$15.6M 0.42% 75
2015
Q1
$53M Buy
729,940
+39,215
+6% +$2.79M 0.53% 52
2014
Q4
$47.7M Buy
690,725
+53,050
+8% +$3.58M 0.48% 76
2014
Q3
$41.4M Sell
637,675
-160,895
-20% -$10.2M 0.44% 71
2014
Q2
$49.6M Sell
798,570
-27,100
-3% -$1.62M 0.51% 49
2014
Q1
$48.6M Sell
825,670
-32,200
-4% -$1.8M 0.51% 60
2013
Q4
$43.8M Buy
857,870
+132,275
+18% +$6.62M 0.46% 80
2013
Q3
$36.5M Buy
725,595
+53,145
+8% +$2.78M 0.42% 96
2013
Q2
$33M Buy
+672,450
New +$36.6M 0.4% 101

Other funds holding LLY

Wedge Capital Management's LLY Position: Q2 2026 in Review

Wedge Capital Management reduced its Eli Lilly (LLY) stake by 9.6% in Q2 2026, selling an estimated $82.8K and leaving 764 shares worth $916K. The position accounts for 0.02% of the portfolio, ranked #418.

Wedge Capital Management first reported a position in LLY in Q2 2013 and has held it in 40 quarters since. The position peaked at $53M in Q1 2015. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Wedge Capital Management held 764 shares of Eli Lilly worth $916K as of Q2 2026.
  • Wedge Capital Management sold 81 Eli Lilly shares in Q2 2026, an estimated $82.8K.
  • Eli Lilly made up 0.02% of Wedge Capital Management's portfolio in Q2 2026, its #418 holding.
  • Wedge Capital Management first reported a position in Eli Lilly in Q2 2013 and has held it in 40 quarters since.
  • Wedge Capital Management's Eli Lilly position peaked at $53M in Q1 2015.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Wedge Capital Management's 13F filing for Q2 2026, filed 10 Jul 2026.